Drug Information
Drug (ID: DG01848) and It's Reported Resistant Information
Name |
Interferon alfa-2B
|
||||
---|---|---|---|---|---|
Synonyms |
INTERFERON ALFA-2B; 98530-12-2; Interferon alfa-2b, recombinant; C16H17Cl3I2N3NaO5S; SCHEMBL6041041; K779; Q4391540
Click to Show/Hide
|
||||
Indication |
In total 1 Indication(s)
|
||||
Structure | |||||
Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(1 diseases)
Head and neck cancer [ICD-11: 2D42]
[1]
|
||||
Target | Interferon-alpha 2 (IFNA2) | IFNA2_HUMAN | [1] | ||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
7
|
||||
IsoSMILES |
CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+]
|
||||
InChI |
InChI=1S/C15H16Cl3N3O2.CH2I2O3S.Na/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18;2-1(3)7(4,5)6;/h3,5,8-10H,2,4,6-7H2,1H3;1H,(H,4,5,6);/q;;+1/p-1
|
||||
InChIKey |
MIXCUJKCXRNYFM-UHFFFAOYSA-M
|
||||
PubChem CID | |||||
TTD Drug ID | |||||
DrugBank ID |
Type(s) of Resistant Mechanism of This Drug
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Head and neck cancer [ICD-11: 2D42]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: MX dynamin like GTPase 1 (MX1) | [1] | |||
Molecule Alteration | Up-regulation | Interaction |
||
Resistant Disease | Head and neck squamous cell carcinoma [ICD-11: 2D42.1] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | HN30 cells | Nasopharyngeal | Homo sapiens (Human) | CVCL_5525 |
HN4 cells | Nasopharyngeal | Homo sapiens (Human) | CVCL_IS30 | |
HN6 cells | Tongue | Homo sapiens (Human) | CVCL_8129 | |
In Vivo Model | BALB/c nude mice model | Mus musculus | ||
Experiment for Molecule Alteration |
Overexpression assay | |||
Experiment for Drug Resistance |
Flow cytometry assay | |||
Mechanism Description | LncMX1-215 negatively regulates immunosuppression by interrupting GCN5/H3K27ac binding in HNSCC. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.